Navigation Links
New Data Demonstrates 5-FU Personalized Chemotherapy Management (PCM(R)) Assay Provides Similar Performance to More Complicated Liquid Chromatography-Mass Spectrometry (LC-MS/MS)
Date:6/23/2008

BETHLEHEM, Pa., June 23 /PRNewswire/ -- A new blood test may make it easier for oncologists to accurately measure and personalize 5-fluorouracil (5-FU) dosing for patients undergoing continuous infusion chemotherapy regimens. Data from a multicenter trial showed that a nanoparticle-based immunoassay from Saladax Biomedical, called 5-FU Personalized Chemotherapy Management (PCM(R)), performed as well as high performance liquid chromatography (HPLC) or LC-MS/MS, but was easier to use, more rapid and more amenable to widespread clinical use. The data was presented at the 2008 Hematology/Oncology Pharmacy Association and the International Society of Oncology Pharmacy Practitioners' (HOPA/ISOPP) annual meeting in Anaheim, Calif.

5-FU is a cornerstone treatment regimen for colorectal cancer; the third leading cause of cancer deaths in the United States.(i)

"This evidence-based tool for monitoring the actual drug concentrations of 5-FU in the blood will enable simplified, personalized dose management with the goal of minimizing toxicity and maximizing the therapeutic benefit of 5-FU treatment," said Salvatore Salamone, Ph.D., CEO of Saladax Biomedical. "This is important because a significant amount of scientific evidence over the last decade demonstrates that the effectiveness of the 5-FU regimen is burdened by potentially severe and life-threatening side effects."

To date, analysis of 5-FU blood plasma levels could only be performed by complex, labor-intensive, expensive, and physical analytical methods such as HPLC that have insufficient capacity to be used in high volume clinical settings. The 5-FU PCM assay could provide the same HPLC or LC-MS/MS-like performance, while offering advantages of automation, small sample size, and improved turn-around time for oncologists.

The multicenter study evaluated 5-FU blood plasma levels at three sites, according to the Clinical and Laboratory Standards Institute (CLSI) protocol. 5-FU blood plasm
'/>"/>

SOURCE Saladax Biomedical
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease
2. Phase 1/2 Trial of Motexafin Gadolinium Plus Antibody Targeted Radiation Therapy Demonstrates High Complete Response Rate in Patients With Non-Hodgkins Lymphoma
3. Micromets BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkins Lymphoma
4. Further Clinical Testing of BZL101 in Advanced Breast Cancer Demonstrates Favorable Efficacy and Toxicity Profiles
5. Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer
6. Phase I/II Study of Targeted Gene Delivery In Vivo - Intravenous Infusions of REXIN-G - Demonstrates Dose-Dependent Anti-Tumor Activity Without Toxicity in Patients With Progressive Chemo-Resistant Bone and Soft Tissue Sarcoma (ASCO 2008)
7. Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration
8. Tioga Pharmaceuticals Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome
9. New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients
10. Study Demonstrates Lexapro(R) Significantly Improves Depression Symptoms in Adolescents
11. Clinical Data Demonstrates 5-Year Efficacy and Safety of Aquamid(R) in Facial Augmentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... NEW YORK, May 6, 2015 Delcath Systems, ... medical device company focused on oncology with an emphasis ... announces financial results for the three months ended March ... quarter and recent weeks include: , Achieved quarterly ... than 43% compared with the first quarter of 2014; ...
(Date:5/6/2015)... , May 6, 2015 CVS Health (NYSE: CVS ... Baltimore locations that sustained heavy fire damage during ... in Baltimore over the past week or ... is ahead," said CVS Health President and CEO Larry Merlo ... path to better health. There is no better way that we ...
(Date:5/6/2015)... Fibich, Leebron, Copeland, Briggs & Josephson is ... been reached to resolve lawsuits involving individuals who were ... - manufactured by Takeda Pharmaceuticals - has been associated ... of the firm,s attorneys were instrumental in the coordination ... Fibich - Founding Partner of Fibich, Leebron, Copeland, ...
Breaking Medicine Technology:Delcath Reports 2015 First Quarter Financial Results 2Delcath Reports 2015 First Quarter Financial Results 3Delcath Reports 2015 First Quarter Financial Results 4Delcath Reports 2015 First Quarter Financial Results 5Delcath Reports 2015 First Quarter Financial Results 6Delcath Reports 2015 First Quarter Financial Results 7Delcath Reports 2015 First Quarter Financial Results 8CVS Health Announces it Will Rebuild Baltimore CVS/pharmacy Locations 2Takeda Agrees to $2.4 Billion Settlement for Actos Bladder Cancer Lawsuits 2
... JERSEY CITY, N.J., May 2, 2011 Aoxing ... Pharma"), a specialty pharmaceutical company focusing on research, ... products, announced that its operating subsidiary in China, ... a patent by the State Intellectual Property Office ...
... International, Inc. (NYSE: VRX ) (TSX: VRX) today ... and Cephalon, Inc. (NASADQ: CEPH) on their announcement that Cephalon ... the news, Valeant has withdrawn its consent solicitation. ... Cephalon stockholders and we are pleased that Teva has paid ...
Cached Medicine Technology:Aoxing Pharmaceutical Company Announces Issuance of Chinese Patent for Naloxone Sublingual Film 2Aoxing Pharmaceutical Company Announces Issuance of Chinese Patent for Naloxone Sublingual Film 3Valeant Pharmaceuticals Congratulates Teva and Cephalon on Their Transaction 2
(Date:5/6/2015)... 06, 2015 As Hilo Medical ... EMR Adoption Model, the hospital looked for new ... and automate processes. The leadership team realized that ... electronic workflows, patient registration still required patients to ... With HIMSS Stage 7 attestation fast approaching, Hilo ...
(Date:5/6/2015)... Experienced Vancouver air conditioning installation and repair ... will now conduct their cooling services, including air conditioning ... commercial and residential units. Strata complex air conditioning services ... technical knowledge as well as a professionally trained staff. ... take away any old air conditioning unit to be ...
(Date:5/6/2015)... Vancouver, BC (PRWEB) May 06, 2015 ... colon hydrotherapy supplier, is excited to announce a ... will help reduce the industry’s carbon footprint while ... These kits feature Eco-Flex™, the world’s ... “This is a game-changer for hydrotherapists,” claims the ...
(Date:5/6/2015)... Animals make just as good friends as they do ... health. An Ohio veterinarian has been observing this ... health advantages of owning a pet. , “When animals and ... ownership, there are proven health benefits for people-- including physical, ... the Animal Medical Center of Streetsboro said. Every ...
(Date:5/6/2015)... Inversion Studios, a full-service training ... Pilates classes, provides personalized individual instruction and now ... its new Pilates Ring magic circle. , Inversion ... stronger, more centered and graceful, Inversion Studios and ... to healthy fitness through yoga and Pilates. With ...
Breaking Medicine News(10 mins):Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 2Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 3Health News:Pro Ace Care Now Does Air Conditioning Installation for Strata Complexes 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 3Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 2Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 3Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 2Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 3
... than that, after a lumpectomy for breast cancer. Researchers from ... ubiquitous tummy fat , can in fact be used to ... two birds with one stone, a flatter belly and a ... a 'supercharged' fat mixture into the breast tissue after it ...
... a genetic marker that increases a person's risk of colon ... 10-year study was conducted by a team of researchers from ... Public Health, the Catalan Institute of Oncology in Spain, the ... Israel Institute of Technology, including Stephen Gruber and Gad Rennert. ...
... announced today that ALIGN(R) is now available through ... builds and maintains a natural defense against ... as constipation, diarrhea, abdominal discomfort, urgency, gas and ... contains Bifantis(R) (Bifidobacterium infantis 35624), a natural probiotic ...
... western media, the government of the Peoples Republic of China ... the countrys Food and Drug Administration. ,,He was ... of dereliction of duty at a trial in May. ... led to several deaths. , ,China has been ...
... Microsoft, aware that a large number of Internet searches ... presence in the healthcare sector . This, claims Cambridge ... healthcare professionals and medical device manufacturers. According to a ... are already having to come to terms with informed ...
... to detect a disease in its very early ... slowly gaining greater acceptance across Europe . Furthermore, ... and invasive procedures, in addition to reducing bed ... Europe, age-related diseases such as cancer, Alzheimer's disease, ...
Cached Medicine News:Health News:Stem Cells In Belly Fat To Enhance Or Reconstruct Breasts 2Health News:Food Safety Chief Executed for Bribery in China 2Health News:Food Safety Chief Executed for Bribery in China 3Health News:Food Safety Chief Executed for Bribery in China 4Health News:Battle Between Google and Microsoft Could Trigger Revolution in Healthcare 2Health News:Pharmacogenomic Market Gaining Greater Acceptance Across Europe 2Health News:Pharmacogenomic Market Gaining Greater Acceptance Across Europe 3
QC 900 is an assayed quality control material for analyzers measuring hematocrit by electrical conductivity methodologies. It is available in two (2) levels for monitoring analyzer performance at var...
... 823 is an assayed quality ... the performance of blood gas, ... instrumentation. It is available in ... analyzer performance at varying points ...
... QC 463 is a quality control ... monitoring the performance of blood gas, electrolyte, ... practical alternative to the use of human ... in three (3) levels for monitoring analyzer ...
... and probe system used together to quantify ... based system is a sandwich nucleic acid ... for RNA detection and quantification, by amplifying ... technology. Branched DNA allows immediate quantification of ...
Medicine Products: